Association between serotonin transporter gene polymorphisms and increased suicidal risk among HIV positive patients in Uganda by Kalungi, Allan et al.
RESEARCH ARTICLE Open Access
Association between serotonin transporter
gene polymorphisms and increased suicidal
risk among HIV positive patients in Uganda
Allan Kalungi1,2* , Soraya Seedat3, Sian M. J. Hemmings4, Lize van der Merwe5, Moses L. Joloba6, Ann Nanteza1,
Noeline Nakassujja7, Harriet Birabwa8, Jennifer Serwanga9, Pontiano Kaleebu9 and Eugene Kinyanda2,7,10
Abstract
Background: Persons living with HIV/AIDS (PLWHA) are at an increased risk of suicide. Increased suicidal risk is a
predictor of future attempted and completed suicides and has been associated with poor quality of life and poor
adherence with antiretroviral therapy. Clinical risk factors have low predictive value for suicide, hence the interest in
potential neurobiological correlates and specific heritable markers of suicide vulnerability. The serotonin transporter
gene has previously been implicated in the aetiology of increased suicidal risk in non-HIV infected study populations
and its variations may provide a platform for identifying genetic risk for suicidality among PLWHA. The present
cross-sectional study aimed at identifying two common genetic variants of the serotonin transporter gene and their
association with increased suicidal risk among human immunodeficiency virus (HIV)-positive adults in Uganda.
Results: The prevalence of increased suicidal risk (defined as moderate to high risk suicidality on the suicidality module
of the Mini Neuropsychiatric Interview (M.I.N.I) was 3.3% (95% CI, 2.0–5.3). The 5-HTTLPR was found to be associated
with increased suicidal risk before Bonferroni correction (p-value = 0.0174). A protective effect on increased suicidal risk
was found for the 5-HTTLPR/rs25531 SA allele (p-value = 0.0046)- which directs reduced expression of the serotonin
transporter gene (5-HTT).
Conclusion: The SA allele at the 5-HTTLPR/rs25531 locus is associated with increased suicidal risk among Ugandan
PLWHA. Further studies are needed to validate this finding in Ugandan and other sub-Saharan samples.
Keywords: Suicidal risk, Serotonin transporter (5-HTT) gene polymorphisms, HIV/Aids, Uganda
Background
HIV/AIDS is associated with a considerable risk of
suicide with studies reporting rates of between 7.8% to
43%, [1–5]. Increased suicidal risk is a predictor of
future attempted and completed suicides, and has been
associated with poor quality of life and poor adherence
with antiretroviral therapy [6–8]. While considerable
work has been undertaken to understand psychosocial
and clinical risk factors for suicidal risk, these have low
predictive value for suicide, hence the interest in
potential neurobiological correlates and specific heritable
markers of suicide vulnerability [1, 2, 9]. Evidence from
genetic and epidemiological studies suggests that genes
play an important role in the predisposition to suicidal
behavior [10, 11]. There is also evidence that suicidal
behavior may aggregate in families independently of the
familial transmission of major depression [12], sug-
gesting the existence of independent genetic risk
factors for suicidal behavior [13]. A disturbance in
serotonin (5-HT) transmission is the most frequently
reported neurobiological abnormality associated with
suicidal behavior [14, 15].
The serotonin transporter (5-HTT) is known to
influence serotonergic transmission by regulating the
duration of serotonin in the synaptic cleft. The gene
encoding 5-HTT (5-HTT) is located on chromosome
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17 and is composed of 14 exons [16]. Several 5-HTT
polymorphisms have been identified [17]. Two of the
most commonly studied 5-HTT polymorphisms are
an insertion/deletion polymorphism located 1.2 kb
upstream of the transcription initiation site of the 5-
HTT-linked polymorphic region (5-HTTLPR) and a
variable number of tandem repeat polymorphism, lo-
cated in the second intron of the gene [18] and ab-
breviated as STin2.VNTRs. The 5-HTTLPR
polymorphism has been widely investigated for its
role in increased suicidal risk and in other psychiatric
disorders, mainly in western populations. [19, 20].
This polymorphism comprises two main alleles based
on the presence or absence of a 44 base pair frag-
ment. The first is a 14-repeat short (S) variant with
less transcriptional activity and lower serotonin up-
take from synaptic clefts and the second is the 16-
repeat long (L) variant which has been found to pos-
sess more transcriptional activity [20]. In addition,
Lesch et al. [9] found the S-allele to be significantly
associated with reduced 5-HTT binding in the brain,
and lower 5-HTT mRNA expression and 5- HT up-
take in lymphoblasts, relative to the LL genotype [20].
A meta-analysis found a significant association be-
tween the 5-HTTLPR S allele and suicidal behavior
[21]. The S allele was also found to increase the risk
of developing a depressive episode, and suicidal idea-
tion following exposure to stressful life events, early
adverse environments, maltreatment and childhood
physical and sexual abuse [19, 22–24].
More recently, a polymorphism has been reported in
the 5-HTT gene on human chromosome 17, designated
as rs25531 which is an A to G substitution [25]. The
presence of A or G allele results in LA, SA, LG and SG al-
leles. LA and SA alleles are associated with increased
transcriptional activity of the 5-HTT gene and are thus
referred to as “overexpressing” alleles, while LG and SG
are associated with reduced transcriptional activity of
the 5-HTT, referred to as “low-expressing” alleles. A
study by Roy et al. 2007 [26] found that the low-
expressing alleles (LG and SG) increased the risk of sui-
cidal behavior in male African-American substance
dependent patients exposed to childhood trauma.
The STin2 VNTR is found in intron 2 and consists of
multiple repeat copies of a 16–17 bp element [27]. Three
major alleles have been described, containing 9 (STin 2.9),
10 (STin 2.10) and 12 (STin 2.12) repeats of the 16–
17 bp repetitive element. These STin2 VNTRs have
been found to support differential gene expression in
vitro [20, 28, 29]. For example, Lovejoy et al. [28]
demonstrated that the 9, 10 and 12 repeat elements within
the VNTR domain yielded extremely high levels of enhan-
cer activity relative to the cytomegalovirus supported con-
trol, with the 9-repeat allele exhibiting greater enhancer
activity in an embryonic stem cell model. In addition, Ali
et al. [30] reported on an interaction between the STin2
VNTR and 5-HTTLPR to regulate expression of the 5-
HTT. They reported that the STin2.10 and STin2.12
variants, which alone did not support additional activity,
in conjunction with the S-allele (S10 and S12) directed
higher transcriptional activity of the 5-HTT. However, no
study has examined this polymorphism and increased
suicidal risk in the context of HIV/AIDS. In addition, the
STin2 variant has not been widely studied in suicidal
behavior. Only a few studies have shown a significant as-
sociation between polymorphisms at this site and suicidal
behavior [31].
There is a paucity of data from sub-Saharan Africa
on genetic risk factors for increased suicidal risk.
Additionally, globally, there is an absence of studies
on genetic risk factors for suicidality among patients
living with HIV/AIDS. To address these gaps we
undertook a study to investigate the genetic risk fac-
tors associated with particular suicidal behavior phe-
notypes in the sub-Saharan African setting of Uganda
among persons living with HIV/AIDS. We hypothe-
sized that the overexpressing alleles of the serotonin
transporter gene variants would confer increased sui-
cidal risk to the bearer.
Methods
Study design
This cross-sectional, genetics sub-study was part of a
bigger EDCTP funded project that primarily investigated
risk factors for psychiatric disorders among adults with
HIV/AIDS in Uganda [32]. All consenting eligible HIV-
infected patients attending the study health facilities
during the specified study period were enrolled until the
required sample size (N = 600) was attained. To be
eligible, study participants had to be registered at the
participating HIV clinics, not on anti-retroviral therapy
(ART), 18 years or older, fluent in English or Luganda
(the local language into which the study instruments
were translated), and physically and mentally well
enough to complete the interview (not suffering from a
severe physical and mental disorder to require immedi-
ate medical and psychiatric attention). Participants who
had defaulted on their most recent clinic visit were
excluded.
Participants
Study participants were recruited by the parent study
from two HIV clinics run by The AIDS Support
Organisation (TASO) at Entebbe hospital (semi-urban
site) and Masaka hospital (rural site) between 6th
May 2010 and 30th October 2012. Study participants
completed a structured interview (undertaken by
trained psychiatric nurses) that included, amongst
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others, a socio-demographic proforma and the suicidality
module of the Mini International Neuropsychiatric Inter-
view (M.I.N.I) [33]. Increased risk for suicide was defined
as moderate to high risk suicidality, as per the suicidality
module of the M.I.N.I. This structured interview, includ-
ing the MINI suicidality module, was administered in the
local language of Luganda (main language spoken in cen-
tral and southwestern Uganda). The MINI has previously
been translated into the local Luganda language using a
process of forward and backward translation by teams of
mental health professionals who were independent of each
other, with a consensus meeting held to resolve any
discrepancies [32]. Blood specimens (5 ml) were obtained
via venipuncture into EDTA tubes, aliquoted and stored
for the subsequent genetics and immunological analyses.
Genotyping
Genomic DNA was extracted from whole blood samples
using the QIAamp DNA Blood Mini Kit (Manchester,
United Kingdom). Polymerase chain reactions (PCR)
was carried out in 25 μl reaction volumes containing be-
tween 20 and 205 ng template DNA, 200 μM dNTP
(Kapa Biosystems, Cape Town, South Africa), 5 μl of
10X Taq DNA polymerase buffer (Kapa Biosystems,
Cape Town, South Africa), 1.0 mM magnesium chloride
(Kapa Biosystems, Cape Town, SA), 0.625 units (U) Taq
DNA polymerase (Kapa Biosystems, Cape Town, SA),
and 0.5 μM of each primer, with bi-distilled water. All
PCR-amplification reactions were performed in a
GeneAmp PCR System 9700 (Perkin Elmer Biosystems,
Foster City, CA, USA).
For the 5-HTTLPR/rs25531 polymorphism, an initial
denaturation step was performed at 95 °C for 3 min.
Thereafter, a denaturation step was performed at 95 °C
for 15 s (s), followed by the primer annealing step, at
60 °C for 15 s, and an elongation step, performed at 72 °
C for 15 s. A final elongation step, at 72 °C for 10 min, was
then performed. The denaturation and extension steps were
repeated for 35 cycles using 5′ -FAM-ATGCCAGCACC-
TAACCCCTAATGT3’ and 5′-GGACCGCAAGGTGGGCG
GGA3’ forward and reverse primers respectively that were
adapted from Voyiaziakis et al. [34]. After amplification,
products were electrophoresed on 2.0% agarose gels, in so-
dium borate buffer at 120 V (V) for about 40 min, using
GelStar (KapaBiosystems, Cape Town, SA) stain, with the
L- and S-alleles resulting in fragments of 419 bp and
375 bp, respectively. In order to discriminate between the
rs25531 A and G alleles, 5 μl of the remaining amplicon
was digested using 5 U MspI restriction endonuclease
(New England Biolabs, United Kingdom) in a 10 μl reaction
overnight at 37 °C, 5ul of the digested product was
subjected to capillary electrophoresis on the ABI 3130 XL
Genetic Analyzer (Applied Biosystems). Fragment sizes of
the alleles at the 5-HTTLPR/rs25531 locus were as follows:
SA/SA = 281 bp; LA/LA = 325 bp; SG/SG, LG/LG, LG/
SG = 151 bp; LG/SA = 151 bp + 281 bp and LA/SG, LA/
LG = 325 bp + 151 bp.
For the STin2 VNTR polymorphism, an initial denatur-
ation step was performed at 95 °C for 2 min. Thereafter, a
denaturation step was performed at 95 °C for 30 s (s),
followed by the primer annealing step, at 60 °C for 30s,
and an elongation step, performed at 72 °C for 30s. A final
elongation step, at 72 °C for 5 min, was then performed.
The denaturation and extension steps were repeated for
35 cycles using 5′-HEX-GTCAGTATCACAGGCTGC-
GAG 3′ and 5′ TGTTCCTAGTCTTACGCCAGTG 3′ for-
ward and reverse primers respectively that were adapted
from Battersby and colleagues [35]. The PCR products
were run on a 1.5% agarose gel in order to determine the
success of the PCR, before the samples were loaded on
the ABI analyser.
Sample preparation and analysis on the ABI prism
The loci containing the 5-HTTLPR/rs25531, and STin2
VNTR polymorphisms were amplified individually.
Following agarose electrophoresis to determine success
of each PCR, the amplicons and the digested products
were combined in a 1:1 ratio for allele-specific size
discrimination analysis, which was performed on the
ABI 3130 XL Genetic Analyzer (Applied Biosystems,
Foster City, United States of America). The multiplexed
samples were then sent to the Central Analytical
Facilities (CAF) laboratory at Stellenbosch University,
where analysis on the ABI prism was done.
Statistical analysis
Functions from R, a language and environment for stat-
istical computing, and R packages genetics, haplo.stats
and MASS, were used for all statistical analyses. R is
freely available from URL http://www.R-project.org. Spe-
cifically, functions from genetics were used to derive
genotype and allelic distributions and to test the Hardy-
Weinberg Equilibrium (HWE), while allelic combina-
tions and their frequencies were inferred with functions
from haplo.stats.
Logistic regression was used to model the different
definitions of increased suicidal risk susceptibility
(dichotomous outcome: increased suicidal risk defined
as either lifetime attempted suicide or past month
attempted suicide) and ordinal logistic regression
(function polr from R package MASS to model the 3
categories of increased suicidal risk (low, moderate and
high risk), as defined by the suicidal risk assessment
criteria of the suicidal risk module of the M.I.N.I. These
models allowed us to control for potential confounders
(study site, socio-economic status and major depressive
disorder).
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P-values for tests of association between the serotonin
transporter gene polymorphisms and increased suicidal
risk were generated. Firstly, these were obtained as nom-
inal p-values without Bonferroni correction (α = 0.05).
To perform a Bonferroni correction, the p-value thresh-
old of 0.05 was divided by 9 (number of separate tests)
to yield a corrected threshold p-value of 0.0056 (see
Table 4).
Ethical considerations
Ethics approval was obtained from the Uganda Virus Re-
search Institute Science and Ethical Committee (Ref #
GC/127/11/08/04) and the Uganda National Council of
Science and Technology (Ref# HS 1053). All study par-
ticipants provided informed consent to participate in the
study and for a blood specimen to be withdrawn from
them for the genetics analyses. Study participants who
were diagnosed with significant psychiatric problems
were referred to mental health units at Entebbe and
Masaka government hospitals and their care clinicians
were notified and follow-up care was arranged.
Results
Socio-demographic and clinical variables are shown in
Table 1.
Prevalence of increased suicidal risk
The prevalence of increased suicidal risk, according
to the criteria for ‘moderate to high suicidal risk’ on
the M.I.N.I., was 3.3% (95% CI, 2.0–5.3), with a life-
time rate of attempted suicide of 6.3% (95% CI, 4.5–
8.8) and a past month rate of attempted suicide of
2.2% (95% CI, 1.2 to 4.0) (Table 2).
Distribution of the alleles and genotypes for the 5-
HTTLPR, 5-HTTLPR/rs25531 and STin2.VNTR
The allele and genotype distributions of 5-HTTLPR, 5-
HTTLPR/rs25531 and STin2 VNTR are presented in
Table 3.
The genotype distribution at the STin2 VNTR and 5-
HTTLPR deviated significantly from HWE (p = 0.0036
and p = 0.0054 respectively) (Table 4).
The estimated effect of the LA allele was to increase
the odds of an individual being in a higher suicide risk
category (from no to low, or low to moderate) by 53%
(95% CI: 12% to 112% (p = 0.0068) before Bonferroni
correction while the addition of an SA allele reduced the
odds of an individual being in a higher suicide risk
category by 43% (95% CI: 14 to 63% (p = 0.0046) after
Bonferroni correction.
There was also a significant association of the
genotypes LALA, LA/SA, LA/LG and LA/SG (representing
genotypes found to be associated with increased expres-
sion of 5-HTT) versus the genotypes SA/SA, SA/LG, LG/
LG, LG/SG and SG/SG (representing genotypes found to
be associated with reduced expression of 5-HTT) with
increased suicidal risk outcome (p-value 0.0145).
However this association became non-significant after
Bonferroni correction (Table 4). For the STin2 VNTR,
the rare 9-repeat allele was absent in the sample.
Discussion
In this study, we investigated the genetic risk for
increased suicidality among HIV positive persons in
Uganda. To our knowledge, this is the first sub-Saharan
African study to investigate the association of polymor-
phisms in 5-HTT and increased suicidal risk, and the
first such study in the world to investigate this risk
among persons living with HIV/AIDS. In this study, the
Table 1 Counts (%) of the characteristics of the study group
Characteristic Count (%)
Site
Entebbe 214 (39)
Masaka 341 (61)
Sex
Male 131 (24)
Female 424 (76)
Education Level
Primary or less 406 (73)
Secondary and above 147 (27)
Marital Status
Married 274 (50)
Not married 279 (50)
Employment Status
Farmer 168 (31)
Not a farmer 382 (69)
Duration of awareness of HIV status
< 12 months 145 (26)
12 months or more 407 (74)
Religion
Catholic 306 (55)
Protestant 107 (19)
Other 142 (26)
Other: Muslims, Born-again Christians, Seventh Day Adventists etc. combined
Table 2 The prevalence of increased suicidal risk as defined by
three criteria of increased suicidal risk
Increased suicidal risk Prevalence Per 100 (95% CI)
Attempted suicide life-time 35 of 553 6.3 (4.5 to 8.8)
Attempted suicide past month 12 of 537 2.2 (1.2 to 4.0)
No, Low, Moderate and High
suicidal risk (according to MINI)
18 of 547 3.3 (2.0 to 5.3)
CI. Confidence Interval, MINI, Mini International Neuropsychiatric Interview
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prevalence of moderate to high risk suicidality, accord-
ing to the MINI, was 2.2%. Kinyanda and colleagues,
2012a [1], using a similar methodology in a study under-
taken at government run HIV clinics at the semi-urban
site of Entebbe, reported a prevalence of increased
suicidal risk of 7.8% and lifetime attempted suicide of
3.9%. [1]. Rukundo and colleagues (2016), in a semi-
urban HIV clinic in south-western Uganda and using a
different method for assessing suicidal risk, reported a
prevalence of suicidal ideation of 8.8% and lifetime
attempted suicide of 3.1% [2]. These rates from Uganda
are, however, much lower than those reported elsewhere:
26% for suicide ideation in the USA [3], 43% for suicidal
ideation in China [4], 31% in United Kingdom [7], 21%
in Australia [36] and 26.9% in Europe and America
(from a systematic review) [5]. The reasons for these
differences include diversity of assessment methods for
suicide risk and differences in underlying suicide risk
associated with particular HIV risk categories (in HIV
endemic countries like Uganda the HIV risk category is
the general population while in the west and in China
the HIV risk categories are men who have sex with men
and intravenous drug users). For a complete discussion,
see Kinyanda and colleagues 2012a [1].
A recent review provided evidence for an association
between 5-HTT and suicidal behavior [13]. 5-HTT has
been a focus of investigation in affective disorders. A
better understanding of these genetic variants and others
that control 5-HTT function (including non-5-HTT
sources of epistasis) will be important in predicting the
effects of 5-HTT variation on a variety of emotional phe-
notypes associated with increased suicidal risk [37].
In the brain, impulses are passed from one nerve cell
to another via a synapse. The pre-synaptic cell releases
serotonin (5-HT) into the synaptic cleft, where it inter-
acts with both post- and presynaptic receptors. At the
presynaptic side, 5-HT activates 5-hydroxytryptamine
(serotonin) receptor 1A (HTR1A), B (HTR1B), and D
(HTR1D), which in turn relays the signal [38]. About
90% of 5-HT is sent back to the pre-synaptic cell. 5-
HTT clears 5-HT from the synaptic clefts, regulating the
strength and duration of serotonergic signaling. Ho et
al., [39] observed a significant difference in 5-HTT avail-
ability in the thalamus (measured by positron emission
tomography 5-HTT imaging technique) in major depres-
sion patients and healthy controls. Overexpression of 5-
HTT leads to more serotonin transporter in the synaptic
cleft [17, 20] and increases the efficiency of serotonin
transportation back into the pre-synaptic cell resulting in
serotonin not to linger at the synapse. This consequently
leads to a shorter action of serotonin. Reduced serotonin
activity is thus expected to be found in the neurons of in-
dividuals with the LA allele. These individuals are probably
at an increased risk of developing major depression, as
Table 3 Allele and genotype distribution for 5-HTTLPR, 5-HTTLPR
and STin2.VNTRs polymorphisms of the serotonin transporter gene
5-HTTLPR
Genotype distribution: Count (Frequency)
L/L 358 (0.65)
L/S 155 (0.28)
S/S 38 (0.07)
5-HTTLPR/rs25531
Genotype distribution Count (Frequency)
LA/LA 223 (0.40)
LA/SA 121 (0.22)
LA/LG 116 (0.21)
LA/SG 3 (0.01)
SA/SA 34 (0.06)
SA/LG 32 (0.06)
LG/LG 23 (0.04)
LG/SG 1 (0.00)
SG/SG 4 (0.01)
STin2. VNTRs
Genotype distribution Count (Frequency)
12/12 317 (0.57)
12/10 182 (0.33)
10/10 55 (0.10)
5-HTTLPR, serotonin transporter linked polymorphic region; L, long allele; S,
short allele; L/L, long long; L/S, long short and S/S, short short genotypes; LA,
and SA are over expressing alleles while LG and SG are under expressing alleles
of the 5-HTTLPR/rs25531 locus; STin2, Serotonin transporter intron 2; VNTRs,
Variable number of tandem repeats; 10, 10 repeat VNTRs and 12, 12 repeat
VNTRs for STin2 VNTRS
Table 4 Association between the 5-HTTLPR, rs25531 and STin2.
VNTR and increased suicidal risk
Polymorphism/
allele
Suicide risk categories
No Bonferroni
correction (α = 0.05)
With Bonferroni
correction (α =0.0056)
Genotype Allelic Genotype Allelic
STin2.VNTRs *0.0285 0.0285
5-HTTLPR *0.0174 0.0174
rs25531 0.6125 0.6125
5-HTTLPR-rs25531 0.0732 0.0732
LA *0.0068 0.0068
SA *0.0046 *0.0046
LG 0.3491 0.3491
SG 0.5686 0.5686
Func_Comb *0.0145 0.0145
p values were corrected for study site, socio-economic status and major
depressive disorder
*Significant effect, Func_Comb = Functional combination (over expressing
(LA, SA) vs lower expressing (LG, SG alleles). The STin2.VNTRs, serotonin
transporter intron 2 variable number of tandem repeats, rs25531, A to G single
nucleotide polymorphism at position 25,531 of the serotonin transporter
gene, 5-HTTLPR-rs25531, Serotonin transporter linked polymorphic region
–rs25531 haplotype
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dysfunction of serotonin neurotransmission has been as-
sociated with occurrence of major depressive disorder
[40]. As depression has been found to be an independent
predictor of moderate-to-high suicidal risk among ambu-
latory HIV patients in Uganda [1], we hypothesized that
the overexpressing alleles would be the risk alleles for in-
creased suicidal risk. A nominally significant association
between the 5-HTTLPR and increased suicidal risk (p-
value = 0.0174) was found with the S-allele being protect-
ive and the L-allele being a risk factor for suicidality. Pre-
vious studies of the 5-HTTLPR have found the S-allele to
be a risk factor for increased suicidality [41], while others
have found no significant association [42]. The discrep-
ancy in findings may be related to sample size, sample eth-
nicity or other confounders such as sampling methods.
Thus proper control for confounders is critical when repli-
cating studies.
The 5-HTTLPR-rs25531 LA allele was found to be associ-
ated with an increased risk of suicidality (p-value = 0.0068),
with a 53% increase in the odds of an individual being in a
higher suicide risk category (from no-to-low, or low-to-
moderate risk) if they carry the LA allele (95% CI: 12% to
112%), however this association became less significant
after Bonferroni correction. The LG and SG alleles
were not significantly associated with increased sui-
cidal risk (p-values = 0.3491 and 0.5686 respectively),
while individuals possessing the SA allele were found
to have a 43% (95% CI: 14 to 63%) reduction in odds
of increased suicidal risk (p-value = 0.0046).
Our results are somewhat in line with those from previ-
ous studies. Henriette et al. [43] found a statistically sig-
nificant protective effect of the 5-HTTLPR S-allele for
suicide among individuals below 35 years of age with a
contrasting statistically significant protective effect of the
high expression genotype (L-allele) for individuals be-
tween 35 and 49 years in a Danish sample. We did not
stratify for age, thus the significance of age suggested by
Henriette was not tested for. In addition, Goldman et al.,
2010 [44] observed low rates of depression, despite a high
frequency of the S-allele, among an East Asian population.
Also, among Caucasians of American descent, those with
the S/S genotype had lower 5-HIAA levels than those with
either L/L or L/S genotypes [45]. These findings seem to
suggest that the S-allele is protective against depression in
African-Americans and East-Asian populations, unlike in
Caucasian populations, where it acts as a risk allele. The
discrepancy amongst these different populations could be
due to linkage disequilibrium between the S- allele and
other 5-HTT polymorphisms, such as the functional single
nucleotide polymorphisms (SNPs) at rs25532 and rs6355
[37], that may result in a reversal of the effect of the S/S
genotype on serotonin turnover among Africans or
African-Americans which may be absent in Caucasian
populations.
The association of 5-HTTLPR with increased suicidal
risk has been contradictory across various ethnicities.
However, a recent review by Schild et al. [46] has
reported a protective role of the S allele in Caucasian
populations, whilst acting as a risk factor in non-
Caucasian populations. In the present study, the SA allele
was protective against increased suicidal risk, a finding
similar to that observed among Caucasians [46]. The
discrepancy between findings of Goldman et al. [46] and
those of Schild et al. [46] may be due to the fact that the
non-Caucasians referred to by Goldman et al. [44] were
of East Asian origin. Extrapolating previous findings
seems difficult for samples of African ethnicity since there
is paucity of data in the field. The contradiction in
findings among Caucasians, Asians and African-
Americans/Africans seems to suggest differences in 5-
HTT risk alleles and suicidality among different races,
supporting the finding by Schild and colleagues [46]
that ethnicity moderates the association between 5-
HTTLPR and national suicide rates.
A nominally significant association between the STin2
VNTR and increased suicidal risk (p-value = 0.0285) was
found in the present study. However, this association
became non-significant after Bonferroni correction. The
STin2.12 allele increased the odds of an individual falling
into a higher suicidal risk category group, while the
STin2.10 allele decreased these odds. A study by Bah
and colleagues [47] found an association of the STin2.12
allele with a history of suicide attempts, which concurs
with our findings. However, a previous study by Lopez
de Lara and colleagues [48] found a significant associ-
ation of suicide completion with having at least a copy
of the STin2.10 allele. Another study by Lee and col-
leagues [31] found the STin2.10 allele to be associated
with suicidal behavior. Findings by Lee et al. [31] and
Lopez de Lara et al. [48] are in agreement, whilst contra-
dicting those of the present study, which are in agree-
ment with the findings of Bah et al. [47]. Mackenzie and
Quinn, [49] reported the STin2.12 to possess greater
transcription activity of the 5-HTT than the STin2.10.
The STin2.12 could thus be compared to the overex-
pressing LA allele whilst the STin2.10 could be compared
to the less expressing SA allele. As per our hypothesis
that over expressing alleles of the 5-HTT confer in-
creased suicidal risk to the bearer, the over expressing
LA allele of the 5-HTTLPR/rs25531 was found to be a
risk allele while the lower expressing SA allele was found
to be protective against increased suicidal risk. Since the
STin2.12 compares with LA and STin2.10 compares with
SA in their capacity to direct transcription of the 5-HTT,
this is interesting, as the finding at the polymorphic in-
tron 2 region replicates that at the 5-HTTLPR.
Neither the 5-HTTLPR nor the STin2 VNTRs geno-
types were in Hardy-Weinberg equilibrium (HWE).
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There exist a number of reasons for deviation from
HWE, including selection bias and genotypic errors. In
the present study, it is likely that deviation from HWE
could result from selection bias. Participants were not
randomly selected from the general population, but were
all HIV+ adults who were recruited from HIV care
clinics. Another cause of the Hardy-Weinberg Disequi-
librium (HWD) could have been genotyping errors as
genotyped samples were not re-genotyped in order to
eliminate the presence of genotypic errors. However,
genotyping errors as a cause of HWD is contentious -
McCarthy and colleagues [50] reported, in hypothetical
data, that the presence of HWE was generally not
altered by the introduction of genotyping errors [51],
thus ruling out genotypic errors as the possible cause of
the HWD. Finally, the violation of the assumptions for
HWE could have been due to population stratification
or selection bias as discussed above. Future studies
should endeavour to control for these when sampling.
This is first study to investigate the interactions
between 5-HTTLPR and 5-HTTLPR-rs25531 polymor-
phisms, STin2.VNTR polymorphisms and increased sui-
cidal risk in PLWHA.
Limitations
Population stratification was not controlled for at
analysis. We assumed that majority of our sample was of
Bagandan ethnicity based on the language spoken
(Luganda) and self report. There is a possibility that
some participants were not Bagandan even though they
could speak Luganda, indicating that we may have had
an admixed sampled, resulting in violation of HWE.
Future studies should focus on ethnicity using ancestry
informative markers to delineate subjects genetically,
rather than basing ethnic differentiation on language
spoken and or self report.
The significant associations of the STin2 VNTRs ob-
served became non-significant when we controlled for
multiple testing using the Bonferroni correction. It is
possible that the significance observed for the above
named polymorphisms may have been due to chance.
Replication studies in the same population are, therefore,
needed to confirm these findings.
Conclusions
Both the LA allele of the polymorphism at the 5-
HTTLPR/rs25531 locus and the 12-repeat of the poly-
morphism at STin2 region in the 5-HTT are risk alleles
for increased suicidal risk among PLWHA in a Ugandan
population.
Results of the present study require replication in a
larger study, which is more equipped to address popula-
tion stratification, and provides more power for associ-
ation analyses.
There is need for further genotyping studies in
Ugandan samples to confirm these findings.
The majority of previous studies have investigated the
5-HTT in Caucasian populations in Europe and America
and more studies are needed in African populations.
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